dc.contributor.author | Sahin, Muammer Melih | |
dc.contributor.author | Yilmaz, Metin | |
dc.contributor.author | Zorlu, Mehmet Ekrem | |
dc.contributor.author | Gocek, Mehmet | |
dc.contributor.author | Duzlu, Mehmet | |
dc.contributor.author | Sayar, Erolcan | |
dc.contributor.author | Ceylan, Alper | |
dc.date.accessioned | 2021-11-09T19:48:50Z | |
dc.date.available | 2021-11-09T19:48:50Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1808-8694 | |
dc.identifier.issn | 1808-8686 | |
dc.identifier.uri | https://doi.org/10.1016/j.bjorl.2019.10.005 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12440/3822 | |
dc.description.abstract | Introduction: Sinonasal inverted papilloma is noted for its high rate of recurrence. Staging systems aid to reduce recurrence and avoid excessive surgeries by guiding the selection of the optimal surgical approach. Objective: To evaluate the effectiveness of different endoscopic approaches in inverted papilloma by assessing tumor origin site and tumor volume. Methods: Krouse classification system that is based on tumor volume was used for staging; furthermore, tumor origin sites were grouped as lateral nasal wall, medial wall and other walls of maxillary sinus. The main treatment method for all patients was endoscopic sinus surgery. Endoscopic extended middle meatal antrostomy, endoscopic Caldwell-Luc and endoscopic medial maxillectomy were the additional surgery types performed in different combinations. Results: Fifty-five patients (42 male) with a mean 54.9 +/- 14.4 years of age were included. 37 patients were diagnosed with advanced stage inverted papilloma (67.2 %). Recurrence was observed in 12 patients (21.8 %). In early stage lateral nasal wall origination, no recurrence was observed in the simple tumor resection group (0/10). In early stage medial wall origination, no recurrence was observed in the extended middle meatal antrostomy group (0/8). In advanced stage medial wall origination, the recurrence rates of extended middle meatal antrostomy, extended middle meatal antrostomy + endoscopic Caldwell- Luc and endoscopic medial maxillectomy were 100.0 %, 53.8 % and 13.6 %, respectively (p =0.002). In advanced stage other walls of maxillary sinus origination, recurrence rates of extended middle meatal antrostomy + endoscopic Caldwell-Luc and endoscopic medial maxillectomy were 20 % and 16.6 %, respectively (p =0.887). Conclusion: Tumor origin site, tumor stage and surgery types show an impact on recurrence. Despite the fact that tumor origin site singly could lead to appropriate selection of the surgery type in most cases, tumor stage carries substantial importance in selection of surgery type for sinonasal-inverted papilloma. An operation plan regarding both tumor volume and tumor origin site may aid surgeons in selecting optimal endoscopic surgical method to avoid recurrence or excessive surgeries. (C) 2019 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Assoc Brasileira Otorrinolaringologia & Cirurgia Cervicofacial | en_US |
dc.relation.ispartof | Brazilian Journal of Otorhinolaryngology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Inverted papilloma | en_US |
dc.subject | Tumor origin site | en_US |
dc.subject | Recurrence | en_US |
dc.subject | Endoscopic approaches | en_US |
dc.title | Does evaluation of tumor volume or/both origination site better guide to optimal surgery for inverted papilloma? | en_US |
dc.type | article | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.description.wospublicationid | WOS:000674583600004 | en_US |
dc.department | Gümüşhane Üniversitesi | en_US |
dc.authorid | Sayar, Erolcan / 0000-0002-3922-5683 | |
dc.authorid | Zorlu, Mehmet Ekrem / 0000-0003-0474-8094 | |
dc.authorid | duzlu, mehmet / 0000-0002-5641-2915 | |
dc.authorid | CEYLAN, ALPER / 0000-0002-6305-4714 | |
dc.identifier.volume | 87 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 396 | en_US |
dc.identifier.doi | 10.1016/j.bjorl.2019.10.005 | |
dc.identifier.endpage | 401 | en_US |
dc.description.pubmedpublicationid | PubMed: 31870739 | en_US |